Page last updated: 2024-09-03

imatinib mesylate and Carotid Artery Diseases

imatinib mesylate has been researched along with Carotid Artery Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grossman, J; Hahn, BH; McMahon, M; Sahakian, L; Skaggs, BJ	1

Other Studies

1 other study(ies) available for imatinib mesylate and Carotid Artery Diseases

Article	Year
Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRβ, chemotaxis and TNFα production. Clinical immunology (Orlando, Fla.), 2010, Volume: 137, Issue:1 Topics: Adult; Apolipoprotein A-I; Benzamides; Carotid Artery Diseases; Cell Line, Tumor; Cell Movement; Chemokine CCL2; Chemotaxis; Cholesterol; Clusterin; Female; Gene Expression; Heart Diseases; Humans; Imatinib Mesylate; Lipoproteins, HDL; Lupus Erythematosus, Systemic; Middle Aged; Molecular Mimicry; Monocytes; Peptides; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Risk Factors; Severity of Illness Index; Tumor Necrosis Factor-alpha	2010

Article

Year

Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRβ, chemotaxis and TNFα production.

Clinical immunology (Orlando, Fla.), 2010, Volume: 137, Issue:1

Topics: Adult; Apolipoprotein A-I; Benzamides; Carotid Artery Diseases; Cell Line, Tumor; Cell Movement; Chemokine CCL2; Chemotaxis; Cholesterol; Clusterin; Female; Gene Expression; Heart Diseases; Humans; Imatinib Mesylate; Lipoproteins, HDL; Lupus Erythematosus, Systemic; Middle Aged; Molecular Mimicry; Monocytes; Peptides; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Risk Factors; Severity of Illness Index; Tumor Necrosis Factor-alpha

2010